Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Yardley, Denise A. and Brufsky, Adam and Coleman, Robert E. and Conte, Pierfranco F. and Cortes, Javier and Glück, Stefan and Nabholtz, Jean-Mark A. and O’Shaughnessy, Joyce and Beck, Robert M. and Ko, Amy and Renschler, Markus F. and Barton, Debora and Harbeck, Nadia (2015) Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Trials, 16 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (870kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Yardley, Denise A.
Brufsky, Adamadb5@pitt.eduADB5
Coleman, Robert E.
Conte, Pierfranco F.
Cortes, Javier
Glück, Stefan
Nabholtz, Jean-Mark A.
O’Shaughnessy, Joyce
Beck, Robert M.
Ko, Amy
Renschler, Markus F.
Barton, Debora
Harbeck, Nadia
Date: December 2015
Date Type: Publication
Journal or Publication Title: Trials
Volume: 16
Number: 1
DOI or Unique Handle: 10.1186/s13063-015-1101-7
Schools and Programs: School of Medicine > Medicine
Refereed: Yes
Date Deposited: 18 Aug 2016 19:54
Last Modified: 04 Nov 2017 05:58
URI: http://d-scholarship.pitt.edu/id/eprint/28937

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item